Some molecular subtypes, such as triple-negative, are significantly associated with lower muscle area values at diagnosis, thus presenting a greater propensity for sarcopenia, a trend also observed in HER2-positive types, compared to luminal-like ones. Here, ERBB2 is linked to sarcopenia.